(25) showed that the percentage of FLT3+ B1 cells in SLE patients was significantly higher than that of healthy controls, while the MYSM1 levels in FLT3+ B1 cells from these patients decreased. The gene discussed is FLT3; the disease is systemic lupus erythematosus.